PROSPECTUS SUPPLEMENT
(To Prospectus Dated January 14, 2019)
$325,000,000
7.00%
Convertible Senior Notes due 2023
Interest payable April 1 and October 1
Issue Price: 100%
We are offering $325,000,000 aggregate principal amount of our 7.00% convertible senior notes due 2023 (the “notes”). The notes will bear interest at a rate of 7.00% per year, payable semi-annually in arrears on April 1 and October 1 of each year, beginning on October 1, 2020. The notes will mature on April 1, 2023, unless earlier repurchased, redeemed or converted.
Holders may convert their notes into shares of our common stock at any time prior to the close of business on the second scheduled trading day prior to the maturity date, unless the notes have been previously repurchased or redeemed by us. The initial conversion rate for the notes will be 153.8461 shares of our common stock per $1,000 principal amount of notes, equivalent to an initial conversion price of approximately $6.50 per share of our common stock. The conversion rate will be subject to adjustment in some events, but will not be adjusted for accrued interest.
If we undergo a fundamental change (as defined herein), holders may require us to repurchase the notes in whole or in part for cash at a fundamental change repurchase price equal to 100% of the principal amount of the notes to be repurchased, plus accrued and unpaid interest, if any, to, but excluding, the fundamental change repurchase date.
We may not redeem the notes prior to their maturity, except to the extent necessary to preserve our status as a real estate investment trust, or REIT, for U.S. federal income tax purposes, as further described in this prospectus supplement. No sinking fund will be provided for the notes.
The notes will be our general unsecured obligations and will rank equal in right of payment with our other existing and future senior unsecured indebtedness and senior in right of payment to any indebtedness that is contractually subordinated to the notes. The notes, however, will be effectively subordinated in right of payment to our existing and future secured indebtedness to the extent of the value of the collateral securing such indebtedness, and structurally subordinated to the claims of our subsidiaries’ creditors, including trade creditors.
We do not intend to apply for listing of the notes on any securities exchange. Our common stock is listed on The New York Stock Exchange, or NYSE, under the symbol “CIM.” On April 7, 2020, the last reported sale price of our common stock on the NYSE was $6.50 per share.
We have elected to be taxed as a REIT for U.S. federal income tax purposes. Any conversion of notes into shares of our common stock will be subject to certain restrictions on ownership and transfer of our stock set forth in our charter and the indenture, as more fully described in “Description of Notes—Ownership Limit; Limitation on Stock Issuable Upon Conversion.”
See “Risk Factors” beginning onpage S-10 of this prospectus supplement and on page 7 of our Annual Report onForm 10-K for the year ended December 31, 2019 to read about important factors that you should consider before investing in the notes.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense.
| | | | |
| | Per Note | | Total |
Public offering price | | 100.00% | | $325,000,000 |
Underwriting discount | | 3.25% | | $ 10,562,500 |
Proceeds, before expenses, to us | | 96.75% | | $314,437,500 |
The offering price set forth above does not include accrued interest, if any. Interest on the notes will accrue from the date of original issuance, expected to be April 13, 2020.
To the extent the underwriters sell more than $325,000,000 principal amount of notes, the underwriters will have the option to purchase within 13 days from the date of this prospectus supplement up to an additional $48,750,000 principal amount of notes from us at the public offering price set forth above, less the underwriting discount, solely to cover over-allotments.
The underwriters expect to deliver the notes in book-entry form only through the facilities of The Depository Trust Company on or about April 13, 2020.
Book Running Manager
Credit Suisse
Co-Managers
| | |
Goldman Sachs & Co. LLC | | Nomura |
April 7, 2020.